RTW INVESTMENTS LP

Adviser information for RTW INVESTMENTS LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 59
Investment Advisory/Research 32
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 10 $8.8B
Non-Discretionary 0 $0
Total 10 $8.8B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 10 $8.8B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 70

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-78183
SEC ERA File Number 801-78183
SEC CIK Numbers 1493215
SEC CRD Numbers 153232
Legal Entity Identifier 54930058PPKTSERDV366

Principal Office

40 10TH AVENUE
7TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:00AM - 6:00PM
Tel: 646-597-6980, Fax: 646-597-6998

Chief Compliance Officer

DARSHAN VISHNU PATEL
40 10TH AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel: 646-876-0039
Fax: 646-597-6998
(Full email address available in API data)

Regulatory Contact

ABDI MOAZAMI
DIRECTOR OF COMPLIANCE
40 10TH AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel: 646-343-9296
Fax: 646-597-6998
(Full email address available in API data)

Industry Affiliates

4010 ROYALTY FUND GP, LLC Sponsor, GP, manager of pooled investment vehicles
HSAC 2 HOLDINGS, LLC Sponsor, GP, manager of pooled investment vehicles
RTW FUND GROUP GP, LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
RTW GLOBAL INVESTMENTS LTD. Other investment adviser, including financial planners
RTW HOLDING LIMITED Sponsor, GP, manager of pooled investment vehicles
RTW HOLDINGS, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
4010 ROYALTY INVESTMENTS ICAV Private Equity Fund $81.1M $0.1M 35
RTW INNOVATION MASTER FUND, LTD. Hedge Fund $3,260.0M $10.0M 349
RTW MASTER FUND, LTD. Hedge Fund $5,060.2M $10.0M 1418

Control Persons

Name Type Entity Title Since Ownership
AURIGEMA, ROBERT, JOHN Individual PARTNER, CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER 08/2020 < 5%
WONG, RODERICK, TZE IAN Individual MANAGING PARTNER, CHIEF INVESTMENT OFFICER 09/2009 > 75%
LOUGHRAN, SABERA, REZA Individual PARTNER EMERITUS 10/2009 < 5%
YALAMANCHI, NAVEEN Individual PARTNER, PORTFOLIO MANAGER 01/2016 10-25%
RTW INVESTMENTS GP, LLC Domestic Entity GENERAL PARTNER OF RTW INVESTMENTS, LP 04/2016 < 5%
PATEL, DARSHAN, VISHNU Individual CHIEF COMPLIANCE OFFICER 02/2021 < 5%
SIROTA, STEPHANIE, ANNE Individual PARTNER, CHIEF BUSINESS OFFICER 01/2014 < 5%
FONG, PETER, M Individual PARTNER, PRESIDENT 01/2022 < 5%
SEITER, CHRISTOPHER, JOHN Individual CHIEF CORPORATE FINANCE OFFICER 04/2021 < 5%
MAKKER, GOTAM Individual PARTNER, HEAD OF STRATEGIC INVESTMENTS 09/2023 < 5%

No. Employees, Historic

70350201920202021202220232024202517 on 11/4/201930 on 3/30/202030 on 6/22/202030 on 6/22/202030 on 2/19/202147 on 3/30/202147 on 9/8/202154 on 3/30/202254 on 5/5/202254 on 11/7/202267 on 3/30/202367 on 5/30/202359 on 3/28/2024

RAUM, Historic

9B5B020192020202120222023202420251784226491 on 11/4/20193565171132 on 3/30/20203565171132 on 6/22/20203565171132 on 6/22/20203565171132 on 2/19/20217983332490 on 3/30/20217983332490 on 9/8/20218730907156 on 3/30/20228730907156 on 5/5/20228730907156 on 11/7/20227179756279 on 3/30/20237179756279 on 5/30/20238820485054 on 3/28/2024

No. Clients, Historic

105020192020202120222023202420255 on 11/4/20196 on 3/30/20206 on 6/22/20206 on 6/22/20206 on 2/19/20218 on 3/30/20218 on 9/8/20217 on 3/30/20227 on 5/5/20227 on 11/7/20227 on 3/30/20237 on 5/30/202310 on 3/28/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
10X GENOMICS INC CL A COM 10M 503K
89BIO INC COM 59M 7M
ACADIA PHARMACEUTICALS INC COM 223M 14M
ACELYRIN INC COM 4M 978K
ADICET BIO INC COM 1M 1M
AKERO THERAPEUTICS INC COM 127M 5M
ALKERMES PLC SHS 170M 7M
ALLURION TECHNOLOGIES INC COM SHS 4M 4M
APOGEE THERAPEUTICS INC COM 107M 3M
ARCA BIOPHARMA INC COM 5M 1M
ARGENX SE SPONSORED ADR 281M 654K
ARVINAS INC COM 79M 3M
ARYA SCIENCES ACQU CORP IV CL A 1M 128K
AVIDITY BIOSCIENCES INC COM 360M 9M
AXSOME THERAPEUTICS INC COM 373M 5M
BRUKER CORP COM 220M 3M
CARGO THERAPEUTICS INC COM 67M 4M
CG ONCOLOGY INC COM 42M 1M
CULLINAN THERAPEUTICS INC COM 18M 1M
CUTERA INC COM 2M 1M
CYTOKINETICS INC COM NEW 147M 3M
CYTOMX THERAPEUTICS INC COM 1M 1M
DIANTHUS THERAPEUTICS INC COM 17M 667K
DYNE THERAPEUTICS INC COM 225M 6M
ESSA PHARMA INC COM NEW 12M 2M
ESTABLISHMENT LABS HLDGS INC COM 122M 3M
EXAGEN INC COM 3M 2M
FULCRUM THERAPEUTICS INC COM 36M 6M
GH RESEARCH PLC ORDINARY SHARES 39M 3M
GLAUKOS CORP COM 46M 386K
IMMATICS N.V SHS 116M 10M
IMMUNIC INC COM 5M 5M
IMMUNOCORE HLDGS PLC ADS 165M 5M
INSMED INC COM PAR $.01 244M 4M
INTUITIVE SURGICAL INC COM NEW 90M 202K
KYVERNA THERAPEUTICS INC COM 14M 2M
LENZ THERAPEUTICS INC COM 15M 863K
MADRIGAL PHARMACEUTICALS INC COM 537M 2M
MASIMO CORP COM 184M 1M
MERUS N V COM 247M 4M
MILESTONE PHARMACEUTICALS IN COM 4M 3M
NATERA INC COM 281M 3M
NEUROGENE INC COM 39M 1M
ORCHESTRA BIOMED HLDGS INC COM 46M 6M
PENUMBRA INC COM 134M 742K
PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS 7M 743K
PROTAGONIST THERAPEUTICS INC COM 183M 5M
PTC THERAPEUTICS INC COM 226M 7M
RADNET INC COM 109M 2M
REGENXBIO INC COM 4M 350K
REPLIMUNE GROUP INC COM 10M 1M
ROCKET PHARMACEUTICALS INC *W EXP 09/02/202 21K 350K
ROCKET PHARMACEUTICALS INC COM 381M 18M
ROIVANT SCIENCES LTD SHS 15M 1M
SAB BIOTHERAPEUTICS INC COM NEW 2M 767K
SAGE THERAPEUTICS INC COM 60M 5M
SAGIMET BIOSCIENCES INC COM SER A 2M 500K
SPYRE THERAPEUTICS INC COM NEW 77M 3M
STOKE THERAPEUTICS INC COM 57M 4M
STRUCTURE THERAPEUTICS INC SPONSORED ADS 5M 125K
TARSUS PHARMACEUTICALS INC COM 93M 3M
TAYSHA GENE THERAPIES INC COM SHS 42M 19M
TEMPUS AI INC CL A 14M 400K
TOURMALINE BIO INC COM 10M 742K
ULTRAGENYX PHARMACEUTICAL IN COM 134M 3M
UROGEN PHARMA LTD COM 60M 4M
VERICEL CORP COM 37M 801K
VIRIDIAN THERAPEUTICS INC COM 8M 606K